{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:15:14Z","timestamp":1790982914417,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1038\/ncpcardio0012","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T12:47:54Z","timestamp":1552654074000},"page":"42-47","source":"Crossref","is-referenced-by-count":79,"title":["Mechanisms of Disease: local renin\u2013angiotensin\u2013aldosterone systems and the pathogenesis and treatment of cardiovascular disease"],"prefix":"10.1038","volume":"1","author":[{"given":"Richard N","family":"Re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpcardio0012_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0025-7125(16)30814-8","volume":"71","author":"RN Re","year":"1987","unstructured":"Re RN (1987) The renin-angiotensin systems. Med Clin North Am 71: 877\u2013895","journal-title":"Med Clin North Am"},{"key":"BFncpcardio0012_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM et al. and RENAAL Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861\u2013869","journal-title":"N Engl J Med"},{"key":"BFncpcardio0012_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/sj.jhh.1001650","volume":"17","author":"GY Lip","year":"2003","unstructured":"Lip GY and Beevers DG (2003) More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2). J Hum Hypertens 17: 747\u2013750","journal-title":"J Hum Hypertens"},{"key":"BFncpcardio0012_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3317\/jraas.2003.002","volume":"4","author":"PL Poulsen","year":"2003","unstructured":"Poulsen PL (2003) ACE inhibitor intervention in type 1 diabetes with low grade microalbuminuria. J Renin Angiotensin Aldosterone Syst 4: 17\u201326","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"BFncpcardio0012_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0025-7125(02)00183-9","volume":"87","author":"S Rajagopalan","year":"2003","unstructured":"Rajagopalan S and Pitt B (2003) Aldosterone as a target in congestive heart failure. Med Clin North Am 87: 441\u2013457","journal-title":"Med Clin North Am"},{"key":"BFncpcardio0012_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0025-7125(03)00124-X","volume":"88","author":"RN Re","year":"2004","unstructured":"Re RN (2004) Tissue renin angiotensin systems. Med Clin N Am 88: 19\u201338","journal-title":"Med Clin N Am"},{"key":"BFncpcardio0012_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/01.CIR.89.1.458","volume":"89","author":"N Von Lutterotti","year":"1994","unstructured":"Von Lutterotti N et al. (1994) Renin is not synthesized by cardiac and extra renal vascular tissues: review of experimental evidence. Circulation 89: 458\u2013470","journal-title":"Circulation"},{"key":"BFncpcardio0012_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI0214276","volume":"109","author":"G Nguyen","year":"1996","unstructured":"Nguyen G et al. (1996) Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417\u20131427","journal-title":"J Clin Invest"},{"key":"BFncpcardio0012_CR9","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/ki.1996.511","volume":"50","author":"G Nguyen","year":"1996","unstructured":"Nguyen G et al. (1996) Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 50: 1897\u20131903","journal-title":"Kidney Int"},{"key":"BFncpcardio0012_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/01.HYP.37.2.710","volume":"37","author":"JJ Saris","year":"2001","unstructured":"Saris JJ et al. (2001) Cardiomyocytes bind and activate native prorenin: role of soluble mannose 6-phosphate receptors. Hypertension 37: 710\u2013715","journal-title":"Hypertension"},{"key":"BFncpcardio0012_CR11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/01.RES.0000019242.51541.99","volume":"90","author":"J Peters","year":"2002","unstructured":"Peters J et al. (2002) Functional significance of prorenin internalization in the rat heart. Circ Res 90: 1135\u20131141","journal-title":"Circ Res"},{"key":"BFncpcardio0012_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/01.RES.84.3.337","volume":"84","author":"S Clausmeyer","year":"1999","unstructured":"Clausmeyer S et al. (1999) An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondria. Circ Res 84: 337\u2013344","journal-title":"Circ Res"},{"key":"BFncpcardio0012_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/01.RES.84.2.240","volume":"84","author":"MA Lee-Kirsch","year":"1999","unstructured":"Lee-Kirsch MA et al. (1999) Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing. Circ Res 1999 84: 240\u2013246","journal-title":"Circ Res"},{"key":"BFncpcardio0012_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1152\/physiolgenomics.2000.3.1.25","volume":"3","author":"PL Sinn","year":"2000","unstructured":"Sinn PL and Sigmund CD (2000) Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics 3: 25\u20133175","journal-title":"Physiol Genomics"},{"key":"BFncpcardio0012_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1210\/endo.140.2.6489","volume":"140","author":"J Peters","year":"1999","unstructured":"Peters J et al. (1999) Losatan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system. Endocrinology 140: 675\u2013682","journal-title":"Endocrinology"},{"key":"BFncpcardio0012_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.85.7.643","volume":"85","author":"DE Dostal","year":"1999","unstructured":"Dostal DE and Baker KM (1999) The cardiac renin-angiotensin system: conceptual, or regulator of cardiac function? Circ Res 85: 643\u2013650","journal-title":"Circ Res"},{"key":"BFncpcardio0012_CR17","first-page":"69","volume-title":"Angiotensin II Receptor Antagonists","author":"J Nussberger","year":"2001","unstructured":"Nussberger J (2001) Circulating versus tissue angiotensin II. In Angiotensin II Receptor Antagonists, 69\u201378 (Eds, Epstein M and Brunner HR) Philadelphia: Hanley and Belfus"},{"key":"BFncpcardio0012_CR18","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1161\/01.CIR.94.8.1886","volume":"94","author":"GGN Serneri","year":"1996","unstructured":"Serneri GGN et al. (1996) Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation 94: 1886\u20131896","journal-title":"Circulation"},{"key":"BFncpcardio0012_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/hh0901.089882","volume":"88","author":"GGN Serneri","year":"2001","unstructured":"Serneri GGN et al. (2001) Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 88: 961\u2013971","journal-title":"Circ Res"},{"key":"BFncpcardio0012_CR20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1046\/j.1523-1755.2000.00973.x","volume":"57","author":"C Delcayre","year":"2000","unstructured":"Delcayre C et al. (2000) Cardiac aldosterone production and ventricular remodeling. Kidney Int 57: 1346\u20131351","journal-title":"Kidney Int"},{"key":"BFncpcardio0012_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","volume":"104","author":"E Harada","year":"2001","unstructured":"Harada E et al. (2001) Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 104: 137\u2013139","journal-title":"Circulation"},{"key":"BFncpcardio0012_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","volume":"103","author":"Y Mizuno","year":"2001","unstructured":"Mizuno Y, et al. (2001) Aldosterone production is activated in failing ventricle in humans. Circulation 103: 72\u201377","journal-title":"Circulation"},{"key":"BFncpcardio0012_CR23","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1161\/01.HYP.0000015905.27598.E9","volume":"39","author":"N Yamamoto","year":"2002","unstructured":"Yamamoto N et al. (2002) Aldosterone is produced from ventricles in patients with essential hypertension. Hypertension 39: 958\u2013962","journal-title":"Hypertension"},{"key":"BFncpcardio0012_CR24","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.172.3988.1138","volume":"172","author":"AI Robertson","year":"1971","unstructured":"Robertson AI and Khairallah PA (1971) Angiotensin rapid localization in nuclei of smooth and cardiac muscle. Science 172: 1138\u20131140","journal-title":"Science"},{"issue":"suppl V","key":"BFncpcardio0012_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0022-2828(89)90772-4","volume":"21","author":"RN Re","year":"1989","unstructured":"Re RN (1989) The cellular biology of angiotensin: paracrine, autocrine and intracrine actions in cardiovascular tissues. J Mol Cell Cardiol 21 (suppl V): 63\u201369","journal-title":"J Mol Cell Cardiol"},{"key":"BFncpcardio0012_CR26","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/01.HYP.25.6.1172","volume":"25","author":"WC De Mello","year":"1995","unstructured":"De Mello WC (1995) Influence of intracellular renin on heart cell communication. Hypertension 25: 1172\u20131177","journal-title":"Hypertension"},{"key":"BFncpcardio0012_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s001090100195","volume":"79","author":"WC De Mello","year":"2001","unstructured":"De Mello WC (2001) Cardiac arrhythmias: the possible role of the renin-angiotensin system. J Mol Med 79: 103\u2013108","journal-title":"J Mol Med"},{"issue":"suppl 11","key":"BFncpcardio0012_CR28","first-page":"S75","volume":"10","author":"H Haller","year":"1999","unstructured":"Haller H et al. (1999) Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10 (suppl 11): S75\u201383","journal-title":"J Am Soc Nephrol"},{"key":"BFncpcardio0012_CR29","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.HYP.28.5.818","volume":"28","author":"B Erdmann","year":"1996","unstructured":"Erdmann B et al. (1996) Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex. Hypertension 28: 818\u2013824","journal-title":"Hypertension"},{"key":"BFncpcardio0012_CR30","doi-asserted-by":"publisher","first-page":"F440","DOI":"10.1152\/ajprenal.2000.279.3.F440","volume":"279","author":"R Chen","year":"2000","unstructured":"Chen R et al. (2000) A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 279: F440\u2013448","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFncpcardio0012_CR31","first-page":"401","volume":"25","author":"RN Re","year":"2003","unstructured":"Re RN (2003) The intracrine hypothesis and intracellular peptide hormone action. Bio Essays 25: 401\u2013409","journal-title":"Bio Essays"},{"key":"BFncpcardio0012_CR32","first-page":"1739","volume":"6 (10\u201311)","author":"RN Re","year":"1984","unstructured":"Re RN and Bryan SE (1984) Functional intracellular renin- angiotensin systems may exist in multiple tissues. Clin Exp Hyperten A 6 (10\u201311): 1739\u20131742","journal-title":"Clin Exp Hyperten A"},{"key":"BFncpcardio0012_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/01.HYP.0000082495.93495.5B","volume":"42","author":"RN Re","year":"2003","unstructured":"Re RN (2003) Intracellular renin and the nature of intracrine enzymes. Hypertension 42: 117\u2013122","journal-title":"Hypertension"},{"key":"BFncpcardio0012_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0014-5793(98)00052-0","volume":"422","author":"C Mercure","year":"1998","unstructured":"Mercure C et al. (1998) Evidence for intracellular generation of angiotensin II in rat juxtaglomerular cells. FEBS Lett 422: 395\u2013399","journal-title":"FEBS Lett"},{"key":"BFncpcardio0012_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0167-0115(93)90251-3","volume":"46","author":"B Bunnemann","year":"1993","unstructured":"Bunnemann B et al. (1993) The renin angiotensin system in the brain: an update 1993. Regul Pept 46: 487\u2013509","journal-title":"Regul Pept"},{"key":"BFncpcardio0012_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/01.HYP.0000125143.73301.94","volume":"43","author":"JL Lavoie","year":"2004","unstructured":"Lavoie JL et al. (2004) Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model. Hypertension 43: 1116\u20131119","journal-title":"Hypertension"},{"key":"BFncpcardio0012_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.0906-6705.2004.0139.x","volume":"13","author":"UM Steckelings","year":"2004","unstructured":"Steckelings UM et al. (2004) Human skin: source of and target organ for angiotensin II. Exp Dermatol 13: 148\u2013154","journal-title":"Exp Dermatol"},{"key":"BFncpcardio0012_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0002-9440(10)64898-5","volume":"160","author":"H Okada","year":"2002","unstructured":"Okada H et al. (2002) Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am J Pathol 160: 765\u2013772","journal-title":"Am J Pathol"},{"key":"BFncpcardio0012_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","volume":"87","author":"A Frustaci","year":"2000","unstructured":"Frustaci A et al. (2000) Myocardial cell death in human diabetes. Circ Res 87: 1123\u20131132","journal-title":"Circ Res"},{"key":"BFncpcardio0012_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00001573-200111000-00002","volume":"16","author":"RN Re","year":"2001","unstructured":"Re RN (2001) The clinical implication of tissue renin angiotensin systems. Curr Opin Cardiol 16: 317\u2013327","journal-title":"Curr Opin Cardiol"},{"key":"BFncpcardio0012_CR41","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1161\/01.HYP.31.6.1324","volume":"31","author":"L Mazzolai","year":"1998","unstructured":"Mazzolai L et al. (1998) Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 31: 1324\u20131330","journal-title":"Hypertension"},{"key":"BFncpcardio0012_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1139\/y02-038","volume":"80","author":"BA Scholkens","year":"2002","unstructured":"Scholkens BA and Landgraf W (2002) ACE inhibition and atherogenesis. Can J Physiol Pharmacol 80: 354\u2013359","journal-title":"Can J Physiol Pharmacol"},{"key":"BFncpcardio0012_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1161\/01.ATV.20.4.915","volume":"20","author":"R Morishita","year":"2000","unstructured":"Morishita R et al. (2000) Antisense oligodeoxy-nucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function. Arterioscler Thromb Vasc Biol 20: 915\u2013922","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpcardio0012_CR44","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/01.CIR.0000061916.95736.E5","volume":"107","author":"CH Wang","year":"2003","unstructured":"Wang CH et al. (2003) C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107: 1783\u20131790","journal-title":"Circulation"},{"key":"BFncpcardio0012_CR45","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nm0901-1003","volume":"7","author":"S AbdAlla","year":"2001","unstructured":"AbdAlla S et al. (2001) Increased AT(1) receptor heterodimers in preeclampsia medicate enhanced angiotensin II responsiveness. Nat Med 7: 1003\u20131009","journal-title":"Nat Med"},{"key":"BFncpcardio0012_CR46","doi-asserted-by":"publisher","first-page":"39721","DOI":"10.1074\/jbc.M105253200","volume":"276","author":"S AdbAlla","year":"2001","unstructured":"AdbAlla S et al. (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276: 39721\u201339726","journal-title":"J Biol Chem"},{"key":"BFncpcardio0012_CR47","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/archinte.163.11.1296","volume":"163","author":"BM Singh","year":"2003","unstructured":"Singh BM and Mehta JL (2003) Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med 163: 1296\u20131304","journal-title":"Arch Intern Med"},{"key":"BFncpcardio0012_CR48","first-page":"227","volume":"31","author":"KB Brosnihan","year":"1998","unstructured":"Brosnihan KB et al. (1998) Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res 31: 227\u2013234","journal-title":"Biol Res"},{"key":"BFncpcardio0012_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"Crackower MA et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 799\u2013802","journal-title":"Nature"},{"key":"BFncpcardio0012_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0021-5155(02)00624-X","volume":"47","author":"T Kida","year":"2003","unstructured":"Kida T et al. (2003) Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human muller cells. Jpn J Ophthalmol 47: 36\u201341","journal-title":"Jpn J Ophthalmol"},{"key":"BFncpcardio0012_CR51","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/sj.bjc.6601646","volume":"90","author":"L Juillerat-Jeanneret","year":"2004","unstructured":"Juillerat-Jeanneret L et al. (2004) Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer 90: 1059\u20131068","journal-title":"Br J Cancer"},{"key":"BFncpcardio0012_CR52","first-page":"199","volume":"2","author":"J Cook","year":"1992","unstructured":"Cook J et al. (1992) The use of antisense oligonucleotides to establish autocrine angiotensin growth effects in human neuroblastoma and mesangial cells. Antisense Nucleic Acid Drug Dev 2: 199\u2013210","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"BFncpcardio0012_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2141.2004.04998.x","volume":"126","author":"WB Strawn","year":"2004","unstructured":"Strawn WB et al. (2004) Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126: 120\u201312655","journal-title":"Br J Haematol"}],"container-title":["Nature Clinical Practice Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0012","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:32:19Z","timestamp":1684423939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio0012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["BFncpcardio0012"],"URL":"https:\/\/doi.org\/10.1038\/ncpcardio0012","relation":{},"ISSN":["1743-4297","1743-4300"],"issn-type":[{"value":"1743-4297","type":"print"},{"value":"1743-4300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}